Salud financiera de hoja de balance de Dr. Lal PathLabs
Salud financiera controles de criterios 5/6
Dr. Lal PathLabs tiene un patrimonio de accionistas total de ₹18.1B y una deuda total de ₹3.0B, lo que sitúa su ratio deuda-patrimonio en 16.6%. Sus activos y pasivos totales son ₹24.5B y ₹6.4B respectivamente. El BAIT de Dr. Lal PathLabs es de ₹4.4B, por lo que su ratio de cobertura de intereses es de -323.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹9.0B.
Información clave
16.6%
Ratio deuda-patrimonio
₹2.99b
Deuda
| Ratio de cobertura de intereses | -323.5x |
| Efectivo | ₹8.97b |
| Patrimonio | ₹18.06b |
| Total pasivo | ₹6.39b |
| Activos totales | ₹24.45b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Recent updates
What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You
May 01Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?
Apr 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) A Risky Investment?
Feb 17With EPS Growth And More, Dr. Lal PathLabs (NSE:LALPATHLAB) Is Interesting
Jan 20Why You Should Care About Dr. Lal PathLabs' (NSE:LALPATHLAB) Strong Returns On Capital
Dec 06Here's Why I Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today
Oct 13Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹10.8B) de LALPATHLAB superan a sus pasivos a corto plazo (₹4.7B).
Pasivo a largo plazo: Los activos a corto plazo de LALPATHLAB (₹10.8B) superan a sus pasivos a largo plazo (₹1.7B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: LALPATHLAB tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de LALPATHLAB ha crecido de 0% a 16.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de LALPATHLAB está bien cubierta por el flujo de caja operativo (173.7%).
Cobertura de intereses: LALPATHLAB gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.